Section 13-7-12 - Coverage for orally administered anticancer medications; limits on patient costs.

NM Stat § 13-7-12 (2019) (N/A)

Copy with citation

Copy as parenthetical citation

A. Group health coverage, including any form of self-insurance, offered, issued or renewed under the Health Care Purchasing Act that provides coverage for cancer treatment shall provide coverage for a prescribed, orally administered anticancer medication that is used to kill or slow the growth of cancerous cells on a basis no less favorable than intravenously administered or injected cancer medications that are covered as medical benefits by the plan.

B. A group health plan shall not increase patient cost-sharing for anticancer medications in order to achieve compliance with the provisions of this section.

C. Coverage of orally administered anticancer medication shall not be subject to any prior authorization, dollar limit, copayment, deductible or coinsurance provision that does not apply to intravenously administered or injected anticancer medication used to kill or slow the growth of cancerous cells.

History: Laws 2011, ch. 55, § 1.

Effective dates. — Laws 2011, ch. 55, § 7 made Laws 2011, ch. 55, § 1 effective June 17, 2011.

Applicability. — Laws 2011, ch. 55, § 6 provided that the provisions of this act apply to insurance policies that provide coverage for cancer treatment and that are delivered, issued for delivery, amended, renewed or continued in this state on or after January 1, 2012.

Previous Section

Section 13-7-11 - Required coverage of patient costs incurred in cancer clinical trials.

Next Section

Section 13-7-13 - Coverage of prescription eye drop refills.